Session Details

S031 Dermatology Review: General

Sat, Mar 8, 1:00 PM - 12:00 AM
W209C
3 CME Available Symposium
View Map

DESCRIPTION

This session will review the current state of knowledge, evaluation, and treatment of atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, lupus, dermatomyositis, and new recommendations for vaccination for adults receiving biologics and oral therapies.

LEARNING OBJECTIVES

1.

Evaluate the latest advances in pathophysiology for atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, and dermatomyositis.

2.

Determine new approaches to evaluation of atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, and dermatomyositis, and discuss new vaccination recommendations for adults receiving biologics and oral therapies.

3.

Review current treatments and new developments for atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, dermatomyositis

SCHEDULE

1:00 PM

Update on Atopic dermatitis

Lisa A Beck, MD, FAAD

1:30 PM

Update on Itch and its treatments

Brian S Kim, MD, FAAD

2:00 PM

Hidradenitis Suppurativa

Haley Naik, MD, FAAD

2:30 PM

Update on Bullous Diseases

Mary M Tomayko, MD, PhD, FAAD

3:00 PM

Update in Cutaneous lupus and Dermatomyositis

Victoria P. Werth, MD, FAAD

3:30 PM

Vaccination recommendations for adults receiving biologics and oral therapies

Christoph Ellebrecht, MD, FAAD

DIRECTOR

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

SPEAKERS

Lisa A Beck, MD, FAAD

Lisa A Beck, MD, FAAD

Christoph Ellebrecht, MD, FAAD

Christoph Ellebrecht, MD, FAAD

Brian S Kim, MD, FAAD

Brian S Kim, MD, FAAD

Haley Naik, MD, FAAD

Haley Naik, MD, FAAD

Mary M Tomayko, MD, PhD, FAAD

Mary M Tomayko, MD, PhD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Lisa A Beck, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); AMGEN – Consultant (1099 relationship)(Honoraria); Apogee BioPharm – Consultant (1099 relationship)(Honoraria); Arcus Biosciences – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Arena Pharmaceuticals – Consultant (1099 relationship)(No Compensation Received); AstraZeneca – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Honoraria); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Honoraria); Belharra Therapeutics – Consultant (1099 relationship)(Honoraria); Celldex – Consultant (1099 relationship)(Honoraria); Dermavent – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Honoraria); Galderma Research & Development, LLC – Consultant (1099 relationship)(Honoraria); Gilead Sciences, Inc – Consultant (1099 relationship)(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Invea Therapeutics – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Consultant (1099 relationship)(Fees); Medtronics – Stockholder(Stock); Merck & Co., Inc – Consultant (1099 relationship)(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); ResVita Bio, Inc – Consultant (1099 relationship)(Honoraria); Ribon Therapeutics – Consultant(Honoraria); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sitryx Therapeutics – Consultant (1099 relationship)(Honoraria); Stealth Biotherapeutics – Consultant (1099 relationship)(Honoraria); TRex Bio – Consultant (1099 relationship)(Honoraria); Triveni Bio – Consultant (1099 relationship)(Honoraria); Tupos Therapeutics – Consultant (1099 relationship)(Honoraria); UCB Pharma – Consultant (1099 relationship)(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Honoraria); Xencor – Consultant (1099 relationship)(Honoraria); Zai Laboratories – Consultant (1099 relationship)(Honoraria);

Christoph Ellebrecht, MD, FAAD

Cabeletta Bio – Founder(Stock);

Brian S Kim, MD, FAAD

AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Alys Pharmaceuticals – Stockholder Private Company(Stock); AstraZeneca – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant(Fees); Septerna – Consultant (1099 relationship)(Fees);

Haley Naik, MD, FAAD

23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Incyte – Other(Grants/Research Funding); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding);

Mary M Tomayko, MD, PhD, FAAD

Astra Zeneca – Advisory Board(Honoraria); Cabaletta Bio – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Honoraria);

Victoria P. Werth, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arionix – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Daiichi Sanko – Consultant (1099 relationship)(Honoraria); Dianthus Therapeutics – Consultant (1099 relationship)(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Innovaderm Research Inc. – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Prolium – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Valuence – Consultant (1099 relationship)(Honoraria); Vindico Medical Education – Speaker/Faculty Education(Honoraria);